Skip to main content

Table 2 Fat distribution

From: No evidence of a synergistic effect of HIV infection and diabetes mellitus type 2 on fat distribution, plasma adiponectin or inflammatory markers

  HIV + DM2+ HIV + DM2- Controls with DM2 Healthy controls P
Total fat (kg) 25.5 (19.8–31.0) 18.8 (14.1–23.4) 28.9 (25.8–32.0) 21.6 (19.3–24.0) 0.002
Trunk fat (kg) 17.2 (13.5–20.9) 12.4 (8.9–15.9) 18.6 (16.2–21.0) 13.0 (11.5–14.6)* 0.002
Limb fat (kg) 7.5 (5.5–9.5) 5.7 (4.1–7.2) 9.5 (8.4–10.5) 7.9 (6.7–9.1) 0.004
Total fat (%) 28.8 (24.4–33.3) 23.4(19.1–27.7) 34.0 (31.5–36.6)* 28.5 (25.8–31.2) 0.001
Trunk fat (%) 34.3 (29.7–38.8) 28.1 (23.0–33.2) 39.4 (36.8–42.0)* 33.5 (30.9–36.2) 0.001
Limb fat (%) 46.6 (36.3–57.0) 36.5 (28.6–44.5) 58.0 (51.6–64.5) 47.6 (41.4–53.8) 0.002
Trunk fat mass/limb fat mass ratio 2.58 (2.18–2.97) 2.34(1.84–2.85) 2.01 (1.77–2.26)* 1.74 (1.55–1.93)* 0.001
  1. Differences between groups were analyzed using one-way ANOVA followed by t-test for comparison between HIV + DM2+ and the 3 control groups. * p ≤ 0.05 compared to HIV + DM2+. Abbreviations: HIV + DM2+ Persons living with HIV with diabetes mellitus type 2, HIV + DM2- Persons living with HIV without diabetes mellitus type 2